(Q50519236)
Statements
Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy. (English)
1 reference
Kyu Seop Kim
1 reference
Won Ki Lee
1 reference
7 June 2011
1 reference
55
1 reference
4
1 reference
370-377
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference